Bellissima DMS brings ink and cost savings

Wilbert Streefland, director at Technology Coaching, conducted comprehensive tests for the study and compared ink usage of an AM (Amplitude Modulated) halftone screen to a Bellissima DM (Digitally Modulated) halftone screen.

The study has confirmed that printing jobs with Bellissima screening technology enables ink savings across the tone range as high as 50 percent at specific tone values. Overall savings of approximately 10 percent of ink can be expected for typical production jobs compared to printing with a traditional AM screen.

‘These results show that Hamillroad's Bellissima Digitally Modulated screen is a significant innovation, any printer that uses it will, without question, benefit from ink savings,’ commented Streefland. ‘Bellissima's screen is more efficient, requiring less ink to produce any given tone value (other than a solid), which results in a significant ink-saving over an AM screen when printing halftone images. A flexo printer using Bellissima will realize a reduction in ink usage and be more environmentally responsible as a result.’

Andy Cave, CEO from Hamillroad, added: ‘We have presentations and prints that explain the theory of how our Digitally Modulated Screening makes ink savings possible. We were always confident of its capabilities to deliver these savings, but it's great that we now have categorical data from these tests to prove it. These independent results furthermore support the savings already measured by customers on real-world jobs in production environments.

‘The opportunities for ink savings at printers and converters are evident in black and white, and we're excited to share this news with the market. Bellissima is shaping the future of the flexo industry, and it is inspiring to be at the forefront of this change.’

Further independent studies quantifying additional cost-saving opportunities with Bellissima are in process and will be available later this year. In addition, the whitepaper detailing the ink savings test procedure and results is available to request on the Hamillroad website.